MARKET

BBP

BBP

Virtus LifeSci Biotech Products ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

51.95
+0.56
+1.09%
Closed 16:00 11/27 EST
OPEN
51.95
PREV CLOSE
51.03
HIGH
51.95
LOW
51.95
VOLUME
138
TURNOVER
--
52 WEEK HIGH
52.14
52 WEEK LOW
30.83
TOTAL ASSET
26.50M
YTD YIELD
3.89%
1D
5D
1M
3M
1Y
5Y
News
Performance
Biotech Investing In A Time Of The Coronavirus
A broad and diverse effort is underway by biotech companies to solve the terrible riddle of the Coronavirus.Firms are forging ahead with testing, treatment and vaccine research and product development.Results of even the most promising treatments, however, are not yet clear cut. Even those that may be are not proof a bullish thesis for those companies that have developed them.Biotech investing is risky. The temptations of building a large position in a COVID 19-engaged public company are obvious.A wise investor would be well-served by opening or adding to such positions with a measure of caution.
Seekingalpha · 10/09 16:49
Biotechnology Innovation During COVID-19
Seeking Alpha - Article · 06/11 07:47
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08 00:01
ACADIA: The Company's Perspectives In Numbers.
Seeking Alpha - Article · 05/15 15:18
Will These Tech Stock Valuations Last?
Seeking Alpha - Article · 02/13 13:06
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Brookfield Asset Management: Strong And Getting Stronger
Seeking Alpha - Article · 10/06/2019 13:28
Aprea Therapeutics upsizes IPO amid turbulent biotech market
Seeking Alpha - Article · 10/03/2019 14:09
More
No Data
Learn about the latest financial forecast of BBP. Analyze the recent business situations of Virtus LifeSci Biotech Products ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-2.4491%
--
3-Month
-1.9357%
--
6-Month
6.0962%
--
1-Year
3.8897%
--
5-Year
7.5540%
--
Since Inception
11.2432%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
Virtus LifeSci Biotech Products ETF
Risk
Low risk
Inception Date
2014-12-16
Benchmark
Dow Jones US Healthcare TR
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Brown/Kadushin